Advertisement

Topics

Perrigo Company Profile

09:46 EST 16th December 2018 | BioPortfolio

Perrigo Company is the USA's largest manufacturer of store brand over-the-counter ("OTC") (non-prescription)pharmaceutical, personal care and nutritional products. Store brand products are sold under a retailer's own label and compete with nationally advertised brand name products. The Company attributes its leadership position in the store brand

market to its comprehensive product assortment and to its commitment to product quality, customer service, retailer marketing support and low cost production.

Location

515 Eastern Avenue
Allegan
MI
49010
United States of America

Contact

Phone: 269 673-8451
Email: OtcComments@perrigo.com


News Articles [58 Associated News Articles listed on BioPortfolio]

Perrigo plans separation of Rx business

Perrigo has announced plans to separate its Prescription Pharmaceuticals (Rx) business following a recent strategic portfolio review. Expected to be...Read More... The post Perrigo plans separation of...

Perrigo appoints new CEO, reshuffling leadership for 3rd time since 2016

Murray Kessler, a former tobacco executive, will replace Uwe Roehrhoff as Perrigo's chief effective immediately.

Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo

Sol-Gel Technologies (NASDAQ:SLGL) a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin disea...

Sol-Gel to develop another generic product with Perrigo

Perrigo will test and market the product, and the two companies will share proceeds from US sales equally.

Perrigo to market non─prescription, OTC Nasonex nasal spray in US

Perrigo Company plc has entered into a licensing agreement with a subsidiary of Merck & Co, Inc., Kenilworth, NJ, USA for the exclusive rights in the United States to pursue regulatory approval for a

Perrigo gibt Dividende bekannt

Der irische Pharmakonzern Perrigo Company PLC (ISIN: IE00BGH1M568, NYSE: PRGO) kündigt eine Quartalsdividende in Höhe von 0,19 US-Dollar an. Die Ausschüttung erfolgt am 18. September 2018 (Record d...

Aktionäre des Pharmakonzerns Perrigo erhalten Dividende

Der irische Pharmakonzern Perrigo Company PLC (ISIN: IE00BGH1M568, NYSE: PRGO) kündigt eine Quartalsdividende in Höhe von 0,19 US-Dollar an. Die Ausschüttung erfolgt am 18. Dezember 2018 (Record da...

Perrigo Settles Patent Litigation for the Generic Version of Picato Gel

NewsPicato (ingenol mebutate) gel, 0.015 percent, 0.05 percent is indicated for the treatment of actinic keratosis.Contributed Author: 

Drugs and Medications [228 Associated Drugs and Medications listed on BioPortfolio]

Bacitracin [Perrigo New York Inc]

Perrigo Bacitracin Drug Facts

Good sense antacid [L Perrigo Company]

Perrigo Antacid Tablets Drug Facts

Tolnaftate [Perrigo New York Inc]

Perrigo Tolnaftate 1% Antifungal Powder Drug Facts

Good sense [L Perrigo Company]

Perrigo Triple Antibiotic Ointment Drug Facts

Good sense gas relief [L Perrigo Company]

Perrigo Gas Relief Drug Facts

PubMed Articles [0 Results]

None

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis.

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

The purpose of this study is to compare safety and efficacy of Perrigo's drug product compared to an FDA approved drug product in the treatment of actinic keratosis.

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

To compare safety and efficacy of Perrigo's antiviral drug product compared to an FDA approved antiviral drug product in the treatment of cold sores.

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel ...

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

To compare safety and efficacy of Perrigo's drug product compared to an FDA approved drug product in the treatment of vulvar and vaginal atrophy.

Companies [4 Associated Companies listed on BioPortfolio]

Perrigo Company

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable he...

Perrigo

Perrigo Company is the USA's largest manufacturer of store brand over-the-counter ("OTC") (non-prescription)pharmaceutical, personal care and nutritional products. Store brand products are sold under ...

Teva Pharmaceutical Industries Ltd. and Perrigo Company

Impax Laboratories, Inc. and Perrigo Company

Impax Laboratories, Inc. (“Impax”) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the developm...

More Information about "Perrigo" on BioPortfolio

We have published hundreds of Perrigo news stories on BioPortfolio along with dozens of Perrigo Clinical Trials and PubMed Articles about Perrigo for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Perrigo Companies in our database. You can also find out about relevant Perrigo Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record